publication date: Dec. 21, 2010

In this issue: 

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians;

Bush To Propose Increase for Cancer Screening, FDA Generics Reviews;

FASEB Urges 10% Increase for NIH in FY04;

NCI Supports New Cervical Cancer Screening Guideline;

Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92

(8-page issue).

Includes January Business & Regulatory Report (8-page issue).

Download (PDF 720KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.